Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review

Bronchodilators are central drugs in the management of patients with chronic obstructive pulmonary disease (COPD). Indacaterol was the first agent of the novel family of very long-acting β2-agonists to be used as an inhaled bronchodilator for COPD and provides 24-hour therapeutic action, thus allowi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridolo, Erminia, Montagni, Marcello, Olivieri, Elisa, Riario-Sforza, Gian Galeazzo, Incorvaia, Cristoforo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3785397/
https://www.ncbi.nlm.nih.gov/pubmed/24082783
http://dx.doi.org/10.2147/COPD.S49179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3785397/
https://www.ncbi.nlm.nih.gov/pubmed/24082783
http://dx.doi.org/10.2147/COPD.S49179

Ejemplares similares